dc.contributorUniversidade Estadual Paulista (UNESP)
dc.date.accessioned2022-04-29T07:14:57Z
dc.date.accessioned2022-12-20T02:30:26Z
dc.date.available2022-04-29T07:14:57Z
dc.date.available2022-12-20T02:30:26Z
dc.date.created2022-04-29T07:14:57Z
dc.date.issued2013-01-01
dc.identifierDrug Metabolism Letters, v. 7, n. 2, p. 105-116, 2013.
dc.identifier1872-3128
dc.identifierhttp://hdl.handle.net/11449/227755
dc.identifier10.2174/1872312808666140317155008
dc.identifier2-s2.0-84901758900
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5407890
dc.description.abstractIn drug discovery and development, the kinetic study of active metabolites plays an important role, helping to define the time course of the drug in the body and its activity or toxicity. After a pharmacokinetics assessment of a drug and its metabolite or a prodrug and its parent-drug, several parameters can be calculated. In some cases, achieving the objective of the study does not require all possible parameters to be calculated. When parameters are calculated, it is essential that their denotations are widely accepted and used. However, some parameters undergo a certain variability of denotation, which may confuse some readers. Thus, this review summarizes the current published data for experimental pharmacokinetic parameters of metabolites and the calculations involved in simple metabolite pharmacokinetic studies. It also evaluates the most common pharmacokinetic parameters in the literature and suggests metabolite parameters that could be determined to help advance metabolite kinetic models. © 2013 Bentham Science Publishers.
dc.languageeng
dc.relationDrug Metabolism Letters
dc.sourceScopus
dc.subjectMetabolite kinetics
dc.subjectPharmacokinetic parameters
dc.subjectPreclinical pharmacokinetics
dc.subjectProdrug pharmacokinetics
dc.titleA review of pharmacokinetic parameters of metabolites and prodrugs
dc.typeOtros


Este ítem pertenece a la siguiente institución